← All trials
NCT05936086
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 20, 2023
- Primary completion
- Apr 20, 2026
- Completion date
- May 20, 2027
- First posted
- Jul 7, 2023
- Last posted
- Aug 30, 2023
- Enrollment
- 160
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Chongqing Medical UniversityLead sponsor
- Chongqing Medical UniversityStudy director
- Chongqing Medical UniversityStudy director
- People's Hospital of ChongqingStudy director
- Chongqing Medical UniversitySponsor investigator
- People's Hospital of ChongqingOfficial
- Chongqing Medical UniversityOfficial
- Chongqing Medical UniversityOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.